(Q50508387)

English

Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (muromonab-CD3).

scientific article published in August 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (muromonab-CD3). (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

immunosuppression

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

sensorineural hearing loss

1 reference

based on heuristic

inferred from title

author name string

C J Hartnick

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

A F Cohen

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

R V Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

Annals of Otology Rhinology and Laryngology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

106

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

8

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

640-642

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens

1 reference

https://api.crossref.org/works/10.1177%2F000348949710600804

21 January 2018

Muromonab CD3. A review of its pharmacology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1177%2F000348949710600804

21 January 2018

Growth factor interactions in cultures of dissociated adult acoustic ganglia: neuronotrophic effects

1 reference

https://api.crossref.org/works/10.1177%2F000348949710600804

21 January 2018

Identifiers

10.1177/000348949710600804

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

release_ixx567njczh2tg3dt53xu45wfm

1 reference

https://api.fatcat.wiki/v0/release/ixx567njczh2tg3dt53xu45wfm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9270425

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50508387&oldid=1839981873"